Responses
Case Report
Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition
Compose a Response to This Article
Other responses
No responses have been published for this article.